Ostenil Plus, Durolane and Synvisc-One are three frequently requested preparations for intra-articular treatment in osteoarthritis. They differ in composition, in the amount per syringe and in the injection schedule: Ostenil Plus contains sodium hyaluronate with mannitol, Durolane contains stabilised hyaluronic acid (NASHA) and Synvisc-One contains hylan G-F 20.
Ostenil Plus: 40 mg sodium hyaluronate with mannitol
Ostenil Plus from TRB Chemedica is a viscoelastic solution with 2.0% sodium hyaluronate. The 2 ml pre-filled syringe contains 40 mg sodium hyaluronate and 0.5% mannitol, a sugar alcohol.
According to the instructions for use, Ostenil Plus is intended for pain and restricted mobility in osteoarthritis of the knee and other large synovial joints such as the hip and shoulder. The instructions for use specify a total of 1 to 3 injections at weekly intervals. The base product Ostenil contains 20 mg sodium hyaluronate in the same volume and no mannitol; here the instructions for use specify 3 to 5 injections at weekly intervals.
Durolane: 60 mg NASHA as a single injection
Durolane from Bioventus contains 60 mg stabilised hyaluronic acid of non-animal origin (NASHA) in a 3 ml pre-filled syringe, corresponding to 20 mg/ml.
According to the instructions for use, a single injection per treatment course is intended. Durolane is used for the symptomatic treatment of mild to moderate osteoarthritis of the knee and hip joints. The preparation is also intended for ankle, shoulder, elbow, wrist, finger and toe joints.
Synvisc-One: 48 mg hylan G-F 20 in 6 ml
Synvisc-One from Sanofi contains 48 mg hylan G-F 20 in 6 ml, corresponding to 8 mg/ml. Hylan G-F 20 is a derivative of hyaluronic acid.
According to the manufacturer's information, Synvisc-One is intended for pain in osteoarthritis of the knee joint and is administered as a single injection; the full 6 ml are injected into one knee. The preparation contains small amounts of avian protein. The variant Synvisc with 3 × 2 ml, by contrast, is intended for the knee as a series of three injections at weekly intervals.
Composition and injection schedule at a glance
| Feature | Ostenil Plus | Durolane | Synvisc-One |
|---|---|---|---|
| Composition | Sodium hyaluronate, 0.5% mannitol | Stabilised hyaluronic acid (NASHA) | Hylan G-F 20 |
| Amount per syringe | 40 mg in 2 ml | 60 mg in 3 ml | 48 mg in 6 ml |
| Concentration | 20 mg/ml | 20 mg/ml | 8 mg/ml |
| Injections according to the manufacturer | 1 to 3 at weekly intervals | 1 per treatment course | 1 |
| Intended joints | Knee and other large synovial joints such as the hip and shoulder | Knee and hip, also ankle, shoulder, elbow, wrist, finger and toe joints | Knee |
| Manufacturer | TRB Chemedica | Bioventus | Sanofi-Aventis |
Further comparisons
You will find further comparisons in the articles Durolane, Monovisc and Cingal compared, Synvisc and Synvisc-One compared and Hyaluronic acid joint injections for knee osteoarthritis.
Order Ostenil Plus, Durolane and Synvisc-One at Novamedo
You will find Ostenil Plus, Durolane and Synvisc-One as well as all other joint injections in the shop. The product pages lead directly to the details, current prices, and online ordering.
For use by qualified medical personnel. Selection and treatment are based on the respective current manufacturer's instructions for use, including indications, contraindications, precautions, and safety information.












